C. Bryan Wait, M.d., Internal Medicine,p.c. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 N Oak St, Columbia City, IN 46725 Phone: 260-244-0238 Fax: 260-244-1976 |
News Archive
In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.
The DePuy Synthes Companies of Johnson & Johnson today announced the launch of the DePuy Synthes CMF MatrixWAVE MMF System, an adaptable wave-patterned bone borne plate and screw system designed for use in the temporary stabilization of mandibular and maxillary fractures and osteotomies.
In the human brain and retina, glutamate is an important messenger that carries information from one neuron to another. The level of glutamate transmitted between neurons is crucial to cell communication: too high and neurons die, too low and the information is not communicated properly. In either case this can contribute to neurological diseases including stroke, glaucoma, and Alzheimer's.
› Verified 4 days ago